Back to Blackstone Inc. Blackstone Inc.

IKTIKT
7 quarters

Position history for Blackstone Inc.Blackstone Inc.'s holdings in INHIBIKASE THERAPEUTICS INC

Blackstone Inc. holds 5.9M shares of IKT (INHIBIKASE THERAPEUTICS INC), worth $12.1M as of 2026-Q2. IKT represents 0.0% of Blackstone Inc.'s portfolio.

Current Value

$12.1M

Current Shares

5.9M

Total Value Change

+$5.3M

Total Shares Change

+3.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
5.9M
0.0%
$12.1M0.0%$2.03
0
2026-Q1
Unchanged
5.9M
0.0%
$10M0.0%$1.91
0
2025-Q4
Increased
5.9M
+125.1%
$12.2M0.0%$1.97
45
2025-Q3
Unchanged
2.6M
0.0%
$4.3M0.0%$1.53
0
2025-Q2
Increased
2.6M
+27.4%
$5.1M0.0%$1.62
34
2025-Q1
Unchanged
2.1M
0.0%
$4.5M0.0%$2.29
0
2024-Q4
New
2.1M
-
$6.7M0.0%$3.24
38

Other major holders of IKT: BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used